Double-Masked Uveitis Treatment

Status: Completed

ClinicalTrials.gov Identifier: NCT01358266

32-007: Phase 3 study of Intravitreal injections of DE-109 in patiens with active, non-infectious uveitis of the posterior segment of the eye.

Condition: Uveitis; Posterior, Disorder

Study Type: Interventional

Duration: 5 years and 7 months

Eligibility:

  • Ages: 18 years and older
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information on this study, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.